THYRO-TABS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Thyro-tabs, and what generic alternatives are available?
Thyro-tabs is a drug marketed by Alvogen and is included in one NDA.
The generic ingredient in THYRO-TABS is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thyro-tabs
A generic version of THYRO-TABS was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for THYRO-TABS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 130 |
| Patent Applications: | 3,229 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | THYRO-TABS at DailyMed |
Pharmacology for THYRO-TABS
| Drug Class | l-Thyroxine |
Anatomical Therapeutic Chemical (ATC) Classes for THYRO-TABS
US Patents and Regulatory Information for THYRO-TABS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | THYRO-TABS | levothyroxine sodium | TABLET;ORAL | 021116-001 | Oct 24, 2002 | AB1,AB2,AB3,AB4 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Alvogen | THYRO-TABS | levothyroxine sodium | TABLET;ORAL | 021116-005 | Oct 24, 2002 | AB1,AB2,AB3,AB4 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Alvogen | THYRO-TABS | levothyroxine sodium | TABLET;ORAL | 021116-010 | Oct 24, 2002 | AB1,AB2,AB3,AB4 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Alvogen | THYRO-TABS | levothyroxine sodium | TABLET;ORAL | 021116-009 | Oct 24, 2002 | AB1,AB2,AB3,AB4 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
